You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 018276

✉ Email this page to a colleague

« Back to Dashboard

NDA 018276 describes XANAX, which is a drug marketed by Upjohn and is included in two NDAs. It is available from seven suppliers. Additional details are available on the XANAX profile page.

The generic ingredient in XANAX is alprazolam. There are fifteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the alprazolam profile page.

Summary for 018276

Tradename:	XANAX
Applicant:	Upjohn
Ingredient:	alprazolam
Patents:	0

Pharmacology for NDA: 018276

Medical Subject Heading (MeSH) Categories for 018276

Anti-Anxiety Agents
GABA Modulators
Hypnotics and Sedatives

Suppliers and Packaging for NDA: 018276

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
XANAX	alprazolam	TABLET;ORAL	018276	NDA	PHARMACIA & UPJOHN COMPANY LLC	0009-0029	0009-0029-01	100 TABLET in 1 BOTTLE (0009-0029-01)
XANAX	alprazolam	TABLET;ORAL	018276	NDA	PHARMACIA & UPJOHN COMPANY LLC	0009-0029	0009-0029-02	500 TABLET in 1 BOTTLE (0009-0029-02)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.25MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.5MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	1MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Expired US Patents for NDA 018276

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-004	Nov 27, 1985	⤷ Subscribe	⤷ Subscribe
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-002	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-003	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-001	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-003	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-004	Nov 27, 1985	⤷ Subscribe	⤷ Subscribe
Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-002	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.